Recursion Pharmaceuticals, Inc. - Class A Common Stock
Recursion Pharmaceuticals, Inc. - Class A Common Stock
Acción · US75629V1044 · RXRX (XNAS)
Resumen Indicadores financieros
5,57 USD
23,23 % 1,05 USD
NASDAQ (XNAS) · Precios actuales y gráficos en MoneyPeak
06.06.2025 23:59

Cotizaciones actuales de Recursion Pharmaceuticals, Inc. - Class A Common Stock

BolsaTickerMonedaÚltima operaciónPrecioVariación diaria
XNAS: NASDAQ
NASDAQ
RXRX
USD
06.06.2025 23:59
5,57 USD
4,56 USD
+22,14 %

Rendimiento

Día Semana Mes 3 meses 6 meses 1 año 5 años
0,00 % 32,62 % 33,25 % -15,48 % -30,38 % -34,55 % -69,06 %

Perfil de la empresa para Recursion Pharmaceuticals, Inc. - Class A Common Stock Acción

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 to treat familial adenomatous polyposis; and REC-3599, which is in Phase I clinical trial to treat GM2 gangliosidosis. Its preclinical stage product includes REC-3964 to treat Clostridium difficile colitis; REC-64917 for the treat of neural or systemic inflammation; REC-65029 to treat HRD-negative ovarian cancer; REC-648918 to enhance anti-tumor immune; REC-2029 for the treatment of wnt-mutant hepatocellular carcinoma; REC-14221 to treat solid and hematological malignancies; and REC-64151 for the treatment of immune checkpoint resistance in KRAS/STK11 mutant non-small cell lung cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Datos de la empresa

Nombre Recursion Pharmaceuticals, Inc. - Class A Common Stock
Empresa Recursion Pharmaceuticals, Inc.
Símbolo RXRX
Sitio web https://www.recursion.com
Mercado principal XNAS NASDAQ
ISIN US75629V1044
Tipo de valor Acción
Sector Healthcare
Industria Biotechnology
CEO Dr. Christopher C. Gibson Ph.D.
Capitalización de mercado 2 Mrd.
País Estados Unidos de América
Moneda USD
Empleados 0,8 T
Dirección 41 South Rio Grande Street, 84101 Salt Lake City
Fecha de OPV 2021-04-16

Símbolos de cotización

Nombre Símbolo
NASDAQ RXRX

Otras acciones

Los inversores que tienen Recursion Pharmaceuticals, Inc. - Class A Common Stock también tienen las siguientes acciones en su cartera:
Hennessy Japan Fund Institutional Class
Hennessy Japan Fund Institutional Class Fondo
UNIL.FIN.NED 18/23 MTN
UNIL.FIN.NED 18/23 MTN Bono
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras. Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Aviso legal Protección de datos Blog Comunidad Comentarios Changelog
Im App Store herunterladen Bei Google Play herunterladen
Todos los derechos reservados © LCP GmbH 2025